NICE Publishes Recommendations for Opdivo, Kevzara and Eylea

Drug Industry Daily
A A
The U.K.’s National Institute for Health and Care Excellence published guidances for three drugs in four indications, recommending their use by the NHS as long as the sponsors comply with patient access programs and agreed-upon discounts.

To View This Article:

Login

Subscribe To Drug Industry Daily